Short answer
Enovis CORP (ENOV) filed its Q4 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Oct 3, 2025. Quarterly revenue was $549M (up 8.6% year over year) with net income of −$571M.
Q4 2025 key financials · XBRL
- Revenue
- $549M
- +8.6% YoY · −2.8% QoQ
- Net income
- −$571M
- −1712.0% YoY · −1454.6% QoQ
- Operating margin
- -101.7%
- Gross margin
- 59.9%
- EPS (diluted)
- −$10.02
- −1627.6% YoY · −1465.6% QoQ
Source: XBRL data from the Enovis CORP (ENOV) Q4 2025 10-Q on SEC EDGAR. USD.
Enovis CORP Q4 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New Goodwill impairment risk triggered by 40% stock price decline, recognized $541M impairment Q3 2025 due to sustained market capitalization decrease
- Updated impairment risk: total $1.186B Goodwill impairments recognized including $645M in 2024 annual test and $541M in 2025 interim assessment
- Legal/regulatory risk from accounting standards requiring non-cash Goodwill impairments based on market conditions, impacting reported earnings adversely
- Operational risk: potential future impairments linked to competitive technologies emerging or declines in acquired business market conditions
- Financial risk: substantial intangible assets, Goodwill impairments materially affect operating results and total capitalization
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Enovis CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.